Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A drug, an endothelin receptor antagonist used to treat pulmonary hypertension.

Etymologies

Sorry, no etymologies found.

Examples

  • Due to competitive concerns with Myogen's ambrisentan, which is expected to enter the market in 2007, timing is of the essence for Encysive.

    Big Pharma Bounces On Q2 Earnings

  • Due to competitive concerns with Myogen's ambrisentan, which is expected to enter the market in 2007, timing is of the essence for Encysive.

    Encysive Shares Clouded By Uncertainty

  • Gilead has a medicine called ambrisentan for the same lung disease in the final stage of human testing generally required for regulatory approval.

    Gilead to Buy Arresto Biosciences for $225 Million to Obtain Lung Medicine - Bloomberg

  • Shares of Myogen fell 10% as investors were disappointed with a recently announced deal with British drug giant GlaxoSmithKline for experimental drug ambrisentan, a treatment for pulmonary arterial hypertension.

    Tysabri News Lifts Drug Stocks

  • Understanding the function of the lung could help in developing other drugs that might fit in with Cayston and ambrisentan.

    Gilead's Big Shift

  • Data on ambrisentan, however, has been very promising; many analysts think the drug can take on Actelion's similar Tracleer.

    Gilead's Big Shift

  • Myogen's lead drug, ambrisentan, is a treatment for a rare disease called pulmonary arterial hypertension, PAH, a blood pressure disorder of the lungs that makes it extremely difficult for patients to breathe.

    Gilead's Big Shift

  • Separately, Myogen said it forged an alliance with British drug giant GlaxoSmithKline for experimental drug ambrisentan, a treatment for pulmonary arterial hypertension.

    Eye On Stocks For Tuesday, March 7, 2006Eye On Stocks For Tuesday, March 7

  • GlaxoSmithKline, which markets Flolan, the current standard-of-care treatment, obtained non-U.S. marketing rights for Myogen's ambrisentan last March in exchange for U.S. rights for Flolan.

    Gilead's Big Shift

  • Myogen's lead drug candidate is ambrisentan, a new type of treatment for pulmonary arterial hypertension, a blood pressure disorder of the lungs.

    Buyouts Lift Biotechs

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.